Literature DB >> 19019086

Sequence independent interferon-alpha induction by multimerized phosphodiester DNA depends on spatial regulation of Toll-like receptor-9 activation in plasmacytoid dendritic cells.

Tobias Haas1, Frank Schmitz, Antje Heit, Hermann Wagner.   

Abstract

Single-stranded versus multimeric phosphorothioate-modified CpG oligodeoxynucleotides (ODNs) undergo differential endosomal trafficking upon uptake into plasmacytoid dendritic cells (pDCs), correlating with Toll-like receptor-9-dependent pDC maturation/activation (single-stranded B-type CpG ODN) or interferon-alpha (IFN-alpha) induction (multimeric A-type CpG ODN), respectively. As was recently shown, IFN-alpha production, other than by CpG ODNs, can also be induced in a sequence-independent manner by phosphodiester (PD) ODNs multimerized by 3' poly-guanosine (poly-G) tails. We investigate here the type of endosomal trafficking responsible for IFN-alpha induction by natural PD ODN ligands. We show that 3' extension with poly-G tails leads to multimerization of single-stranded PD ODNs and to enhanced cellular uptake into pDCs. While monomeric PD ODNs, which induce CpG-dependent Toll-like receptor-9 stimulation and pDC maturation/activation, localized to late endosomal/lysosomal compartments, the poly-G multimerized PD ODNs, which induce CpG-independent IFN-alpha production, located to vesicles with a distinct, 'early' endosomal phenotype. We conclude that poly-G-mediated multimerization of natural PD ODNs allows for sequence-independent, Toll-like receptor-9-dependent IFN-alpha induction in pDCs by combining three distinct effects: relative protection of sensitive PD ODNs from extracellular and intracellular DNase degradation, enhanced cellular uptake and preferential early endosomal compartmentation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019086      PMCID: PMC2632690          DOI: 10.1111/j.1365-2567.2008.02897.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  CpG motifs in bacterial DNA and their immune effects.

Authors:  Arthur M Krieg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

3.  Phosphorothioate backbone modification modulates macrophage activation by CpG DNA.

Authors:  D P Sester; S Naik; S J Beasley; D A Hume; K J Stacey
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

4.  Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo.

Authors:  Alexander H Dalpke; Stefan Zimmermann; Inka Albrecht; Klaus Heeg
Journal:  Immunology       Date:  2002-05       Impact factor: 7.397

5.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

Review 6.  TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.

Authors:  Roberto Baccala; Kasper Hoebe; Dwight H Kono; Bruce Beutler; Argyrios N Theofilopoulos
Journal:  Nat Med       Date:  2007-05       Impact factor: 53.440

7.  The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation.

Authors:  Tobias Haas; Jochen Metzger; Frank Schmitz; Antje Heit; Thomas Müller; Eicke Latz; Hermann Wagner
Journal:  Immunity       Date:  2008-03       Impact factor: 31.745

8.  Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody.

Authors:  Carine Asselin-Paturel; Géraldine Brizard; Jean-Jacques Pin; Francine Brière; Giorgio Trinchieri
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

9.  Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments.

Authors:  Parviz Ahmad-Nejad; Hans Häcker; Mark Rutz; Stefan Bauer; Ramunas M Vabulas; Hermann Wagner
Journal:  Eur J Immunol       Date:  2002-07       Impact factor: 5.532

Review 10.  Lysosomes: fusion and function.

Authors:  J Paul Luzio; Paul R Pryor; Nicholas A Bright
Journal:  Nat Rev Mol Cell Biol       Date:  2007-08       Impact factor: 94.444

View more
  7 in total

1.  Phosphorothioate 2' deoxyribose oligomers as microbicides that inhibit human immunodeficiency virus type 1 (HIV-1) infection and block Toll-like receptor 7 (TLR7) and TLR9 triggering by HIV-1.

Authors:  Joseph A Fraietta; Yvonne M Mueller; Duc H Do; Veronica M Holmes; Mary K Howett; Mark G Lewis; Alina C Boesteanu; Sefik S Alkan; Peter D Katsikis
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

2.  Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects).

Authors:  Cordula Weber; Christian Müller; Anja Podszuweit; Carmen Montino; Jörg Vollmer; Alexandra Forsbach
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

3.  TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN.

Authors:  Jérémy Di Domizio; Ariane Blum; Maighread Gallagher-Gambarelli; Jean-Paul Molens; Laurence Chaperot; Joël Plumas
Journal:  Blood       Date:  2009-06-24       Impact factor: 22.113

Review 4.  Innate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation.

Authors:  Todd V Brennan; Victoria R Rendell; Yiping Yang
Journal:  Front Immunol       Date:  2015-03-16       Impact factor: 7.561

Review 5.  CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies.

Authors:  Nobutaka Hanagata
Journal:  Int J Nanomedicine       Date:  2017-01-16

6.  Binding mode of CpG oligodeoxynucleotides to nanoparticles regulates bifurcated cytokine induction via Toll-like receptor 9.

Authors:  Shanmugavel Chinnathambi; Song Chen; Singaravelu Ganesan; Nobutaka Hanagata
Journal:  Sci Rep       Date:  2012-07-26       Impact factor: 4.379

Review 7.  Toll-like receptor 9 in breast cancer.

Authors:  Jouko Sandholm; Katri S Selander
Journal:  Front Immunol       Date:  2014-07-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.